Accuracy Shipping provides end-to-end logistics services including customs clearance, freight forwarding, and transportation, while also operating fuel retail stations and heavy commercial vehicle dealerships.
The company operates in a highly fragmented and commoditized industry where margins are extremely thin (1.3% net margin), indicating a lack of pricing power. While they claim a 'one-stop-shop' advantage, the low ROCE and sensitivity to freight rate fluctuations suggest no durable competitive barrier.
Management has diversified into unrelated low-margin businesses like fuel retailing and truck dealerships to find 'synergies,' but these have largely diluted overall returns. Capital is primarily reinvested into an asset-heavy fleet and working capital with mediocre incremental returns.
The company's razor-thin margins were finally crushed by a sustained downturn in global freight rates, leaving the business unable to service its heavy debt load. Management's decision to pivot capital into unrelated, low-return ventures like fuel retailing proved to be a value-destructive distraction rather than a hedge. As interest rates rose, the meager 1.33 interest coverage evaporated, forcing a dilutive equity raise or a fire sale of assets to satisfy creditors, while the promoters continued to extract high compensation despite the collapsing bottom line.
RichFakir rates Accuracy Shipping Ltd's business quality as poor — 26/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Accuracy Shipping Ltd is trading about 55% below our estimate of fair value; we rate its price cheap. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Accuracy Shipping Ltd is: Not rated. A poor business at a cheap price — it does not make our shortlist right now.
RichFakir's educational estimate of Accuracy Shipping Ltd's fair value is about ₹8 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →